Conscience, a non-profit focused on accelerating drug discovery in areas of unmet medical need using open science and radical collaboration, is pleased to announce three recipients and projects have ...
WALTHAM, Mass.--(BUSINESS WIRE)--BostonGene, a leader in AI-powered solutions for drug discovery and development, has been honored with the “AI-based Drug Discovery Solution of the Year” award in the ...
Experience the forefront of pharmaceutical innovation as Labroots and the Drug Discovery and Development planning committee host the 9th Annual Drug Discovery & Development Virtual Event on February ...
Traditionally, developing a new drug takes many years and requires a massive financial investment, often involving significant risk and a high likelihood of failure. AI models trained on extensive ...
A multi-well plate with an orange lid being fed into lab equipment. Automation can generate data that train AI models. Credit: Aram Boghosian In late September, I attended “Data & AI to Accelerate ...
OutSee, a genomics and drug discovery company pioneering a unique AI-based predictive genomics approach to target discovery, today announced the closure of its £2.5 M seed funding round. The Company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results